intermediate risk Myelofibrosis
intermediate risk Myelofibrosis is the indication for 2 drugs in DrugBank. It is covered by 4 curated, structured indications.
- Classified under
- Indicated drugs
What you can answer from here — as of November 22, 2026
Which approved drugs for intermediate risk Myelofibrosis share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account